Device Trial Radar · NCT06464107
Endometrial Cell Collection With the PadKit
Last checked: Nov 20, 2026Latest source record: May 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
80
Actual
Start
May 31, 2024
Primary completion
Apr 17, 2026
Study completion Apr 17, 2026
Sponsor
- Lead sponsor
- Hackensack Meridian HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Preprogen
- First posted
- Jun 18, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
All patients will be provided with a Preprogen Pad to be worn for 4-6 hours to collect cells shed by the endometrium. After the kit is returned to the Preprogen laboratory, a brief survey will be completed. Analysis will be conducted to determine if the PadKit™ can collect a sample of endometrial cells sufficient to differentiate between normal and atypical hyperplasia/malignant cells in blinded samples provided to the laboratory for analysis.
Conditions
- Neoplasms
Interventions
PadKit™ from PreprogenDevice
The interlabial pad is classified as a Class 1 device by the FDA and the device is exempt from requiring a 510(k) approval. The interlabial pad is worn for 4-6 consecutive hours and collects cells shed from the cervix and uterine cavity. The pad is then removed and placed in the smaller, inner tube that contains the transport solution. After replacing the lid securely, it is then carefully placed back inside the larger outer tube with the outer lid secured and returned to the original box. The entire box is placed in the polybag and mailed back to the lab for analysis.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Observation of the presence of endometrial cells captured by the pad.Time frame: Within 7 days after receipt of the pad from patients
- Association of the presence/absence of cells and morphologyTime frame: Within 7 days after receipt of the pad from patients
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Jersey Shore University Medical Center
Neptune City, New Jersey
Riverview Medical Center
Red Bank, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.